Lack of control by glucose of ultradian insulin secretory oscillations in impaired glucose tolerance and in non-insulin-dependent diabetes mellitus.

Normal subjects demonstrate the presence of ultradian oscillations (period 80-150 min) in insulin secretion rate (ISR) tightly coupled to glucose oscillations of similar period. These oscillations appear to be a function of the feedback loop linking glucose and insulin. The present study was undertaken to determine whether the control by glucose of the ultradian oscillations in insulin secretion is altered in impaired glucose tolerance IGT and in non-insulin-dependent diabetes mellitus (NIDDM). Patients with NIDDM (n = 7), IGT (n = 4), and matched nondiabetic controls (n = 5) were studied under three separate protocols that involved administration of glucose at either a constant rate of 6 mg/kg per min for 28 h or in one of two oscillatory patterns at the same overall mean rate. The amplitude of the oscillations was 33% above and below the mean infusion rate, and their respective periods were 144 min (slow oscillatory infusion) or 96 min (rapid oscillatory infusion). Insulin, C-peptide, and glucose were sampled at 10-min intervals during the last 24 h of each study. ISRs were calculated by deconvolution of C-peptide levels. Analysis of the data showed that (a) the tight temporal coupling between glucose and ISR in the nondiabetic controls was impaired in the IGT and NIDDM groups as demonstrated by pulse analysis, cross-correlation analysis, and spectral analysis; (b) the absolute amplitude of the ISR pulses progressively declined with the transition from obesity to IGT to NIDDM; and (c) the absolute amplitude of the ISR oscillations failed to increase appropriately with increasing absolute amplitude of glucose oscillations in the IGT and NIDDM subjects compared with the control group. In conclusion, the present study demonstrates that important dynamic properties of the feedback loop linking insulin secretion and glucose are disrupted not only in established NIDDM but also in conditions where glucose tolerance is only minimally impaired. Further studies are needed to determine how early in the course of beta-cell dysfunction this lack of control by glucose of the ultradian oscillations in insulin secretion occurs and to define more precisely if this phenomenon plays a pathogenetic role in the onset of hyperglycemia in genetically susceptible individuals.

[1]  R. Rizza,et al.  Insulin action in non-insulin-dependent diabetes mellitus: the relationship between hepatic and extrahepatic insulin resistance and obesity. , 1987, Metabolism: clinical and experimental.

[2]  G. Weir,et al.  Sustained oscillations of insulin, glucagon, and somatostatin from the isolated canine pancreas during exposure to a constant glucose concentration. , 1980, The Journal of clinical investigation.

[3]  E. Mosekilde,et al.  Aspects of Oscillatory Insulin Secretion , 1991 .

[4]  E. Mosekilde,et al.  Computer model for mechanisms underlying ultradian oscillations of insulin and glucose. , 1991, The American journal of physiology.

[5]  S. O’Rahilly,et al.  Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. , 1988, The New England journal of medicine.

[6]  G. Brechtel,et al.  Effects of Fasting on Plasma Glucose and Prolonged Tracer Measurement of Hepatic Glucose Output in NIDDM , 1987, Diabetes.

[7]  W. Blackard,et al.  Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood. , 1975, The Journal of clinical investigation.

[8]  J. Halter,et al.  Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. , 1984, The Journal of clinical investigation.

[9]  J. A. Scarlett,et al.  Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. , 1981, The Journal of clinical investigation.

[10]  S. Efendić,et al.  Aspects of the pathogenesis of type 2 diabetes. , 1984, Endocrine reviews.

[11]  D. G. Watts,et al.  Spectral analysis and its applications , 1968 .

[12]  A. Lazarow,et al.  Immunoassay of Insulin: Two Antibody System: Plasma Insulin Levels of Normal, Subdiabetic and Diabetic Rats , 1963, Diabetes.

[13]  E. van Cauter Estimating false-positive and false-negative errors in analyses of hormonal pulsatility. , 1988, The American journal of physiology.

[14]  R. Turner,et al.  Cyclic oscillations of basal plasma glucose and insulin concentrations in human beings. , 1979, The New England journal of medicine.

[15]  From Clocks to Chaos: The Rhythms of Life , 1988 .

[16]  B V Howard,et al.  Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. , 1984, The Journal of clinical investigation.

[17]  D. Steiner,et al.  Secretion of Proinsulin C-Peptide by Pancreatic β Cells and its Circulation in Blood , 1969, Nature.

[18]  W. Cleveland Robust Locally Weighted Regression and Smoothing Scatterplots , 1979 .

[19]  R. Turner,et al.  Brief, Irregular Oscillations of Basal Plasma Insulin and Glucose Concentrations in Diabetic Man , 1981, Diabetes.

[20]  P. Bennett,et al.  Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus. , 1990, The Journal of clinical endocrinology and metabolism.

[21]  K. Polonsky,et al.  Oscillations in insulin secretion during constant glucose infusion in normal man: relationship to changes in plasma glucose. , 1988, The Journal of clinical endocrinology and metabolism.

[22]  R. Hamman,et al.  The Effect of Insulin Treatment on Insulin Secretion and Insulin Action in Type II Diabetes Mellitus , 1985, Diabetes.

[23]  R. Wolfe,et al.  Rapid oscillations in plasma insulin, glucagon, and glucose in obese and normal weight humans. , 1982, The Journal of clinical endocrinology and metabolism.

[24]  K. Kosaka,et al.  Insulin Responses in Equivocal and Definite Diabetes, with Special Reference to Subjects Who Had Mild Glucose Intolerance but Later Developed Definite Diabetes , 1977, Diabetes.

[25]  M. Kendall Statistical Methods for Research Workers , 1937, Nature.

[26]  K. Polonsky,et al.  Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. , 1988, The New England journal of medicine.

[27]  D. Steiner On the Role of the Proinsulin C-peptide , 1978, Diabetes.

[28]  K. Polonsky,et al.  Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. , 1988, The Journal of clinical investigation.

[29]  B H Frank,et al.  Quantitative study of insulin secretion and clearance in normal and obese subjects. , 1988, The Journal of clinical investigation.

[30]  W. Duckworth,et al.  Direct measurement of plasma proinsulin in normal and diabetic subjects. , 1972, The American journal of medicine.

[31]  T. R. Hennessy,et al.  Incomplete suppression of hepatic glucose production in non‐insulin dependent diabetes mellitus measured with [6,6‐2H2]glucose enriched glucose infusion during hyperinsulinaemic euglycaemic clamps , 1992, European journal of clinical investigation.

[32]  H. Kuzuya,et al.  Characterization of Seven C-peptide Antisera , 1978, Diabetes.

[33]  E. Ipp,et al.  Pulsatile Insulin Secretion in Isolated Rat Islets , 1990, Diabetes.

[34]  E. Cerasi,et al.  Insulin deficiency and insulin resistance in Type 2 (non‐insulin‐dependent) diabetes: quantitative contributions of pancreatic and peripheral responses to glucose homeostasis , 1987, European journal of clinical investigation.

[35]  A. Rubenstein,et al.  Circulating proinsulin in patients with maturity onset diabetes. , 1977, The American journal of medicine.

[36]  G. Brandenberger,et al.  Ultradian oscillations of plasma glucose, insulin, and C-peptide in man during continuous enteral nutrition. , 1987, The Journal of clinical endocrinology and metabolism.

[37]  Bruce H. Frank,et al.  Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. , 1986, The Journal of clinical investigation.

[38]  R. Turner,et al.  Pulsatile, Synchronous Basal Insulin and Glucagon Secretion in Man , 1982, Diabetes.

[39]  Jeppe Sturis,et al.  Estimation of Insulin Secretion Rates from C-Peptide Levels: Comparison of Individual and Standard Kinetic Parameters for C-Peptide Clearance , 1992, Diabetes.

[40]  J. Halter,et al.  Insulin secretion in diabetes mellitus. , 1981, The American journal of medicine.

[41]  D. Owens,et al.  INSULIN DEFICIENCY IN NON-INSULIN-DEPENDENT DIABETES , 1989, The Lancet.

[42]  J. Sturis,et al.  Entrainment of pulsatile insulin secretion by oscillatory glucose infusion. , 1991, The Journal of clinical investigation.

[43]  D. Kelley,et al.  Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. , 1992, The New England journal of medicine.

[44]  K. Alberti,et al.  Effects of short-term hyperglycemia on insulin secretion in normal humans. , 1986, The American journal of physiology.